This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. vs 57.5%, p=0.010), a greater average number of stents implanted per patient (1.72±0.92 To date, no study has shown the superiority of one type of polymer compared with the other.
While PCI, which includes both angioplasty and stenting, is one of the most common operations in the world, it does carry a small (about 1-2%) but significant risk of death. in total, angioplasty and stenting was deemed to be of low value and potentially avoidable nearly one third of the time.
By inflating a balloon and potentially placing a stent, they can help blood flow more freely from the heart. When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.
Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.
milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.
Balloon angioplasty seems to be the widely preferred treatment of choice. The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. The stenosis was treated with a stent.
In the DA+DCB arm, there was a trend toward higher stent-free patency through 12 months (79.1% versus 68.1%, · P=0.09) and a significantly lower provisional stenting rate (9.5% among 6 randomized controlled trials (RCTs) (172 patients), comparing favorably to published meta-analysis rates for uncoated balloon angioplasty (47.4%
Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006). vs. 28.7%; P=0.006).
Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. The stent-retriever was re-sheathed into the microcatheter before retrieval. Further prospective data is warranted.
A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)
The most important advantage of laser angioplasty or excimer laser angioplasty, is that you need only a standard guidwire, 0.014 inch standard guide wire, unlike the other atherectomy devices which require a bulkier guidewire. Diagrammatic representation of laser angioplasty or atherectomy. One is in-stent restenosis.
This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.
Coronary Artery Stents What are coronary artery stents? A stent is a tiny device made of surgical stainless steel that is placed inside an artery to hold it open and allow blood to flow through the blood vessel. When are coronary stents used? Coronary stents are used as a routine part of most angioplasty procedures.
Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc., There was no restriction on time from last known well (TLKW) to MT.
The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.
This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.
IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).
The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.
Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction 8. EMPACT-MI Trial Outcomes Reported at ACC.24: 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10.
The goal of the AGENT IDE trial was to assess the safety and efficacy of a paclitaxel-coated balloon (drug-coated balloon; DCB) to conventional balloon angioplasty among patients with coronary in-stent restenosis (ISR).
In cases of stent-retriever thrombectomy failure, rescue stentangioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment. 10.43, p=0.0325).Conclusions:The 10.43, p=0.0325).Conclusions:The
Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. 4 Recent literature has reported clinical benefits associated with rescue stenting in the setting of ICAD‐related MT‐refractory strokes.5
The role of intracranial stenting in ICAS remains uncertain. In the SAMMPRIS trial, patients who had experienced recent TIA/CVA secondary to 70‐99% ICAS demonstrated an increased risk of recurrent stroke when treated with angioplasty and stenting compared to medical therapy alone [1].
(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.
All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.
Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent.
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies
A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.MethodsAll patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. At a mean follow-up imaging duration of 28.7 ± 23.6 months
Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.
BACKGROUND:The treatment of complex infra-inguinal disease with drug-coated balloons (DCBs) is associated with a significant number of patients undergoing provisional stenting to treat a suboptimal result. stented versus 70.0% stented versus 68.2% stented versus 45.0% stented versus 19.3% stented versus 45.0%
He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI.
(MedPage Today) -- LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed. DCB with rescue use of.
The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.
Rescue strategies options, including balloon angioplasty alone, rescue stenting (RS) alone, or stent with balloon angioplasty, have shown promise in observational studies and meta‐analyses [3, 4].
If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Hence, in the US, many CTO patients are instead sent for bypass surgery.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content